Back

MYCN mediates cysteine addiction and sensitizes to ferroptosis

Alborzinia, H.; Florez, A. F.; Gogolin, S.; Brueckner, L. M.; Shao, C.; Gartlgruber, M.; Nadler Holly, M.; Ziehm, M.; Paul, F.; Steinhauser, S.; Bell, E.; Shaikhkarami, M.; Hartlieb, S.; Dreidax, D.; Hess, E. M.; Kreth, J.; Poschet, G.; Buettner, M.; Nicke, B.; Stresemann, C.; Reiling, J. H.; Fischer, M.; Amit, I.; Selbach, M.; Herrmann, C.; Woelfl, S.; Henrich, K. O.; Hoefer, T.; Westermann, F.

2021-08-10 cancer biology
10.1101/2021.08.10.455675 bioRxiv
Show abstract

Aberrant expression of MYC family members predicts poor clinical outcome in many human cancers. Oncogenic MYC profoundly alters metabolism and mediates an antioxidant response to maintain redox balance. Here we show that MYC induces massive lipid peroxidation upon depletion of cysteine, the rate-limiting amino acid for glutathione biosynthesis and sensitizes cells to ferroptosis, an oxidative, non-apoptotic and irondependent type of cell death. In MYCN-amplified childhood neuroblastoma, MYCN mediates resistance to ferroptosis by activating transsulfuration of methionine to cysteine. MYCN may contribute to spontaneous tumor regression in low-risk neuroblastomas by promoting ferroptosis in cells with epigenetically silenced cystathionine-beta-synthase, the rate-limiting enzyme for transsulfuration. We identified enzymes and antiporter proteins crucial to ferroptotic escape, providing multiple previously unknown sites that may be acted on therapeutically.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.